Aehr End Period Cash Flow from 2010 to 2024

AEHR Stock  USD 14.25  0.93  6.98%   
Aehr Test End Period Cash Flow yearly trend continues to be relatively stable with very little volatility. End Period Cash Flow is likely to grow to about 51.8 M this year. During the period from 2010 to 2024, Aehr Test End Period Cash Flow destribution of quarterly values had r-value of  0.82 from its regression line and median of  5,513,000. View All Fundamentals
 
End Period Cash Flow  
First Reported
1997-08-31
Previous Quarter
49.2 M
Current Value
40.8 M
Quarterly Volatility
10.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aehr Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aehr Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 1.5 M or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.66. Aehr financial statements analysis is a perfect complement when working with Aehr Test Valuation or Volatility modules.
  
Check out the analysis of Aehr Test Correlation against competitors.

Latest Aehr Test's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Aehr Test Systems over the last few years. It is Aehr Test's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aehr Test's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Aehr End Period Cash Flow Regression Statistics

Arithmetic Mean14,945,163
Coefficient Of Variation118.61
Mean Deviation14,377,529
Median5,513,000
Standard Deviation17,727,144
Sample Variance314.3T
Range53.4M
R-Value0.82
Mean Square Error111.1T
R-Squared0.67
Significance0.0002
Slope3,248,697
Total Sum of Squares4399.5T

Aehr End Period Cash Flow History

202451.8 M
202349.3 M
202230.2 M
202131.6 M
20204.7 M
20195.5 M
20185.4 M

About Aehr Test Financial Statements

Aehr Test shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Aehr Test investors may analyze each financial statement separately, they are all interrelated. The changes in Aehr Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aehr Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow49.3 M51.8 M

Pair Trading with Aehr Test

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.

Moving against Aehr Stock

  0.36AIP ArterisPairCorr
  0.34GFS GlobalfoundriesPairCorr
  0.32CAN Canaan IncPairCorr
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Aehr Stock Analysis

When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.